Immunosuppressive drugs in liver transplant: an insight

C Panackel, JF Mathew, M Jacob - Journal of Clinical and Experimental …, 2022 - Elsevier
Liver transplantation (LT) is the standard of care for end-stage liver failure and
hepatocellular carcinoma. Over the years, immunosuppression regimens have improved …

Liver transplantation in patients with liver failure: twenty years of experience from China

S Ling, G Jiang, Q Que, S Xu, J Chen, X Xu - Liver International, 2022 - Wiley Online Library
Liver transplantation (LT) is the only effective method of treating end‐stage liver disease,
such as various types of liver failure. China has the largest number of patients with hepatitis …

Guidelines for perioperative care for liver transplantation: enhanced recovery after surgery (ERAS) recommendations

R Brustia, A Monsel, S Skurzak, E Schiffer… - …, 2022 - journals.lww.com
Background. Enhanced Recovery After Surgery (ERAS) is a multimodal, evidence-based,
program of care developed to minimize the response to surgical stress, associated with …

The first 5 years of uterus transplant in the US: a report from the United States uterus transplant consortium

L Johannesson, E Richards, V Reddy, J Walter… - JAMA …, 2022 - jamanetwork.com
Importance Uterus transplant is a viable surgical treatment for women affected by absolute
uterine-factor infertility, which affects 1 in 500 women. Objective To review transplant and …

Cost-effectiveness of hepatocellular carcinoma surveillance: an assessment of benefits and harms

ND Parikh, AG Singal, DW Hutton… - Official journal of the …, 2020 - journals.lww.com
DESIGN: We constructed a Markov model to compare surveillance strategies of ultrasound
(US) alone, US and alpha fetoprotein (AFP), and no surveillance in 1 million simulated …

Target-oriented delivery of self-assembled immunosuppressant cocktails prolongs allogeneic orthotopic liver transplant survival

H Xie, H Zhu, KE Zhou, J Wan, L Zhang, Z Yang… - Journal of Controlled …, 2020 - Elsevier
Organ transplantation remains the gold standard therapeutic option for patients with end-
stage organ failure. However, there have been few improvements in the management of …

[HTML][HTML] Update on immunosuppression in liver transplantation

BE Tasdogan, M Ma, C Simsek, B Saberi… - Euroasian journal of …, 2019 - ncbi.nlm.nih.gov
The standard therapy for decompensated end-stage chronic liver disease of any etiology
and acute fulminant hepatic failure is liver transplantation (LT). Advances in …

[HTML][HTML] Outcome and safety of a surveillance biopsy guided personalized immunosuppression program after liver transplantation

EA Saunders, B Engel, A Höfer, B Hartleben… - American Journal of …, 2022 - Elsevier
Graft survival beyond year 1 has not changed after orthotopic liver transplantation (OLT)
over the last decades. Likewise, OLT causes comorbidities such as infection, renal …

Invasive Fungal Infections after Liver Transplantation

T Senoner, R Breitkopf, B Treml, S Rajsic - Journal of Clinical Medicine, 2023 - mdpi.com
Invasive fungal infections represent a major challenge in patients who underwent organ
transplantation. Overall, the most common fungal infections in these patients are …

Non-invasive screening for subclinical liver graft injury in adults via donor-specific anti-HLA antibodies

A Höfer, D Jonigk, B Hartleben, M Verboom… - Scientific reports, 2020 - nature.com
The majority of liver grafts exhibit abnormal histological findings late after transplantation,
even when liver enzymes are normal. Such subclinical graft injuries were associated with …